Recently Viewed

There are no Recent Items


Single User License Price USD 1500
Single User License Price INR 110655
Corporate User License Price USD 4500
Corporate User License Price INR 331965
Site License Price USD 3000
Site License Price INR 221310
Request a Quote

Report Title

ALK-Abello A/S-Product Pipeline Review-2015

Quote Request for License Type
License Type Price  
Single User License USD 1500
Site License USD 3000
Enterprise Wide License USD 4500
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."

Report Title

ALK-Abello A/S-Product Pipeline Review-2015

Quote Request for License Type
License Type Price  
Single User License USD 1500
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."

Report Title

ALK-Abello A/S-Product Pipeline Review-2015

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."

ALK-Abello A/S-Product Pipeline Review-2015

Executive Summary

ALK-Abello A/S-Product Pipeline Review-2015


Global Markets Direct's, 'ALK-Abello A/S-Product Pipeline Review-2015', provides an overview of the ALK-Abello A/S's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of ALK-Abello A/S's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


The report provides brief overview of ALK-Abello A/S including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of ALK-Abello A/S's human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the ALK-Abello A/S's pipeline products

Reasons To Buy

Evaluate ALK-Abello A/S's strategic position with total access to detailed information on its product pipeline

Assess the growth potential of ALK-Abello A/S in its therapy areas of focus

Identify new drug targets and therapeutic classes in the ALK-Abello A/S's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of ALK-Abello A/S and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of ALK-Abello A/S

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of ALK-Abello A/S and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

ALK-Abello A/S Snapshot 5

ALK-Abello A/S Overview 5

Key Information 5

Key Facts 5

ALK-Abello A/S-Research and Development Overview 6

Key Therapeutic Areas 6

ALK-Abello A/S-Pipeline Review 9

Pipeline Products by Stage of Development 9

Pipeline Products-Monotherapy 10

ALK-Abello A/S-Pipeline Products Glance 11

ALK-Abello A/S-Late Stage Pipeline Products 11

Pre-Registration Products/Combination Treatment Modalities 11

Phase III Products/Combination Treatment Modalities 12

ALK-Abello A/S-Clinical Stage Pipeline Products 13

Phase II Products/Combination Treatment Modalities 13

ALK-Abello A/S-Early Stage Pipeline Products 14

Discovery Products/Combination Treatment Modalities 14

ALK-Abello A/S-Drug Profiles 15

MK-8237 15

Product Description 15

Mechanism of Action 15

R&D Progress 15

timothy grass pollen allergen extract 17

Product Description 17

Mechanism of Action 17

R&D Progress 17

Allergen for Olea Europaea Pollen Induced Allergic Rhinitis 19

Product Description 19

Mechanism of Action 19

R&D Progress 19

Allergen for Seasonal Grass Pollen Induced Allergic Rhinitis and Rhino-Conjunctivitis 20

Product Description 20

Mechanism of Action 20

R&D Progress 20

Allergen for Birch Pollen Induced Allergic Rhinoconjunctivitis 21

Product Description 21

Mechanism of Action 21

R&D Progress 21

Allergen for Cupressus Arizonica Pollen Induced Allergic Rhino-Conjunctivitis 22

Product Description 22

Mechanism of Action 22

R&D Progress 22

Allergen for Dog Allergy 23

Product Description 23

Mechanism of Action 23

R&D Progress 23

Allergen for Salsola Kali Pollen Induced Allergic Rhinoconjunctivitis 24

Product Description 24

Mechanism of Action 24

R&D Progress 24

Allergen for Cat Allergy 25

Product Description 25

Mechanism of Action 25

R&D Progress 25

Next Generation Allergy Immunotherapy 26

Product Description 26

Mechanism of Action 26

R&D Progress 26

ALK-Abello A/S-Pipeline Analysis 27

ALK-Abello A/S-Pipeline Products by Route of Administration 27

ALK-Abello A/S-Pipeline Products by Molecule Type 28

ALK-Abello A/S-Recent Pipeline Updates 29

ALK-Abello A/S-Dormant Projects 33

ALK-Abello A/S-Company Statement 34

ALK-Abello A/S-Locations And Subsidiaries 35

Head Office 35

Other Locations & Subsidiaries 35

ALK-Abello A/S-Key Manufacturing Facilities 37

Appendix 38

Methodology 38

Coverage 38

Secondary Research 38

Primary Research 38

Expert Panel Validation 38

Contact Us 38

Disclaimer 39

To know more information on Purchase by Section, please send a mail to

List of Tables

ALK-Abello A/S, Key Information 5

ALK-Abello A/S, Key Facts 5

ALK-Abello A/S-Pipeline by Indication, 2015 8

ALK-Abello A/S-Pipeline by Stage of Development, 2015 9

ALK-Abello A/S-Monotherapy Products in Pipeline, 2015 10

ALK-Abello A/S-Pre-Registration, 2015 11

ALK-Abello A/S-Phase III, 2015 12

ALK-Abello A/S-Phase II, 2015 13

ALK-Abello A/S-Discovery, 2015 14

ALK-Abello A/S-Pipeline by Route of Administration, 2015 27

ALK-Abello A/S-Pipeline by Molecule Type, 2015 28

ALK-Abello A/S-Recent Pipeline Updates, 2015 29

ALK-Abello A/S-Dormant Developmental Projects,2015 33

ALK-Abello A/S, Other Locations 35

ALK-Abello A/S, Subsidiaries 35

ALK-Abello A/S, Key Manufacturing Facilities 37

List of Figures

ALK-Abello A/S-Pipeline by Top 10 Indication, 2015 7

ALK-Abello A/S-Pipeline by Stage of Development, 2015 9

ALK-Abello A/S-Monotherapy Products in Pipeline, 2015 10

ALK-Abello A/S-Pipeline by Top 10 Route of Administration, 2015 27

ALK-Abello A/S-Pipeline by Top 10 Molecule Type, 2015 28

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Current R&D Portfolio of ALK-Abello A/S; ALK-Abello A/S - Key Therapeutics; ALK-Abello A/S - Pipeline Overview and Promising Molecules; ALK-Abello A/S - News; ALK-Abello A/S - Latest Updates; ALK-Abello A/S - Pipeline; ALK-Abello A/S - Discontinued/Dormant Projects

Related Products in vertical


Sign up for newsletter

Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"